772P Phase Ib/II study of durvalumab plus guadecitabine in advanced clear cell renal cell cancer (ccRCC)

Authors :: Monika Joshi
Rohan Garje
D.J. Peace
Ajjai Alva
Yi Sun
Eric A. Singer
A. Lee
Yousef Zakharia
Source :: Annals of Oncology. 31:S594-S595
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Durvalumab
Oncology
Guadecitabine
business.industry
Phase (matter)
Cancer research
Medicine
Cell cancer
Hematology
business
Clear cell

Tools